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ABSTRACT
Galactose is a simple sugar that at supraphysiological concentrations accelerates
aging and age-related complications, which lead to impaired mitochondrial functions.
MitoNEET is a small mitochondrial membrane protein with a molecular mass of 12.2
kDa that functions in diabetes, iron metabolism, regulation of oxidative phosphorylation
(OXPHOS) and reactive oxygen species (ROS) homeostasis. MitoNEET knockdown
increases cellular respiration rates and ROS levels similar to galactose treatment.
Pioglitazone, an antidiabetic drug, binds to mitoNEET and ameliorates galactose toxicity.
Cellular mitoNEET levels, exposure of cells to galactose medium, and pioglitazone
treatment directly influence cellular respiration. To elucidate the role of mitoNEET in
galactose induced toxicity (aging), we measured cellular mitoNEET levels using
immunoblotting technique in galactose and pioglitazone treated human liver cancer cells
(HepG2), as well as isolated synaptosomes from old and young mice. We also monitored
liver cancer cell bioenergetics, using respirometry and calorimetry, of galactose and
pioglitazone treated cells. Immunoblotting revealed treatment with galactose reduced
endogenous mitoNEET levels and those of a chimeric mitoNEET protein fused to a green
fluorescent protein (mNT-GFP), under control of the human cytomegalovirus (CMV)
promotor.

Furthermore, to determine whether mitoNEET mediates pioglitazone

ameliorated galactose toxicity, cells were treated with pioglitazone. Pioglitazone rescued
galactose reduced mitoNEET levels in a dose dependent manner. A concentration of 60
µM pioglitazone reduced cellular mitoNEET levels compared to controls but not mNT
GFP levels. However, pioglitazone at lower concentrations partially restored mitoNEET
levels observed with galactose treatment. Since the synthesis of endogenous mitoNEET
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and m.NT-GFP are regulated by different promoters, D-galactose treatment likely
increased degradation rates of mitoNEET. Moreover, unlike galactose treatment in
HepG2 cells, immunoblotting revealed higher mitoNEET levels in synaptosomes isolated
from aged mice compared to their younger counterparts. We hypothesized that galactose
and pioglitazone interact with mitoNEET and alter cellular bioenergetics.

Acute

treatment with pioglitazone significantly reduced complex I respiration in HepG2 and
HepG2-mNT-GFP cells independent of treatment with galactose. Surprisingly, galactose
treated HepG2-mNT-GFP cells were less sensitive to pioglitazone treatment. HepG2 cells
treated with galactose and HepG2-mNT-GFP cells independent of treatment showed
higher OXPHOS activity compared to controls in absence of galactose, but HepG2-mNT
GFP cells did not respond to galactose treatment. Unlike respiration, galactose treatment
significantly reduced cellular heat flow in HepG2 and HepG2-mNT-GFP cells measured
via calorimetry. However, HepG2-mNT-GFP and pioglitazone treated cells showed
higher heat dissipation compared to control HepG2 cells without galactose. Our results
show that mitoNEET overexpression increases respiration rates and overall energy
transduction in HepG2 cells but does not impact the response to pioglitazone treatment.
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INTRODUCTION
Mitochondria
Aerobic mitochondria in mammalian cells are double membrane bounded
organelles. The outer membrane is made up of a phospholipid bilayer which is permeable
to molecules less than 5000 Da due to the presence of Voltage-dependent Anion Channel
(VDAC) proteins (Lemasters et al., 2006). The nearly impermeable inner membrane is
significantly different from the outer membrane in composition because of the presence
of cardiolipin, respiratory complexes, and remnants of ancestral bacteria (McBride et al.,
2006). The inner membrane is folded into compartmentalized structures called cristae.
Five different enzymatic complexes, which take part in the terminal breakdown of food in
the presence of oxygen termed electron transport chain (ETC), are embedded in the
cristae (Koopman et al., 2013). Three complexes out of five (complex I, complex III and
complex IV) of the ETC pump protons into the intermembrane space establishing proton
motive force (PMF) across the membrane during the reduction of oxygen to water, and
the fifth complex generates ATP (Fig. 1) by using the established PMF (Brown 1992).
In terms of energy requirement, every eukaryotic organism depends on organelles
of mitochondrial origin (mitosomes) which may or may not generate ATP (Miiller et al.,
2012). Most eukaryotic organisms contain mitochondria that produce ATP.

Aerobic

mitochondria exclusively use oxygen as the terminal electron acceptor in the ETC, but
other types of mitochondria, such as anaerobic mitochondria (H2-producing mitochondria
and hydrogenosomes), use chemical compounds other than oxygen for this purpose
(Miiller et al., 2012). The energy required to fuel mitochondrial activity is derived from
organic biomolecules (food materials) which are broken down into simpler units through
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a series of stepwise enzymatic reactions. Glucose (6 carbon sugar) for example is being
broken down into pyruvate (3 carbon alpha-keto acid) in the cell cytoplasm (anaerobic
glycolysis) (Scrutton and Utter 1 968). During this process a part of the chemical energy

��r------ Outer membrane
--=�---

Inter membrane space

Inner membrane
'

----�- Mitochondrial matrix

'

}
}
}

B

}

Outer membrane

Inter membrane space

Inner membrane

Mitochondrial matri>

Figure 1 . Structure of mitochondrion (A) general outline and (B ) in details showing
porous outer mitochondrial membrane due to presence of VDAC protein, respiratory
complexes (I through V) , ubiquinone embedded in inner membrane (Q), cytochrome
c in inter membrane space attached to inner membrane (Cyt-c) and flow of proton
across the inner membrane (dark arrows), (Eng et al. , 2003)

is transferred to the oxidized nicotinamide adenine dinucleotide (NAD+ ) in the form of
electrons generating the reduced form of NADH.

2

In canonical oxygen-respiring

mitochondria (rat-liver type mitochondria), pyruvate generated in the cytoplasm is
transported to the mitochondria via the mitochondrial pyruvate carrier (Halestrap 1975)
Furthermore, pyruvate is broken down into carbon dioxide (C02) and acetyl
Coenzyme A (acetyl-CoA) via pyruvate dehydrogenase complex (Patel and Korotchkina
2006), and acetyl-CoA enters into the tricarboxylic (TCA) acid cycle (also called the
Krebs cycle) located within the mitochondrial matrix to generate intra-mitochondrial
NADH, FADH2 (reduced flavin adenine dinucleotide) and C02 (Femie and Carrari 2004)
. In addition, breakdown of fat takes place in the mitochondrial matrix and peroxisome

and both organelles can generate acetyl-CoA (Lazarow 1978, Wallace et al., 2010).
Similarly, amino acids are first deaminated and decarboxylated and processed to
pyruvate, succinyl-CoA, acetyl-CoA, fumarate, a-keto-glutarate and oxaloacetate, which
are intermediate products of the TCA cycle. The intermediates of the TCA cycle are also
used for the synthesis of other metabolites and precursors of macromolecules including
amino acids, nucleotides etc. (Wallace et al., 2010, Reddy and Reddy 2011). Unlike
pyruvate, the cytosolic proton carrier NADH is not transported into the mitochondrial
matrix but their oxidation supports the malate-aspartate shuttle system through the
cytosolic NADH/cytochrome c electron transport pathway. Two different pathways, the
glutamate dehydrogenase pathway and the aspartate aminotransferase pathway, generate
a-ketoglutarate inside the mitochondria. The malate-aspartate shuttle system is linked to
the a-ketoglutarate generated by glutamate dehydrogenase (Abbrescia et al., 2012).
The mitochondrial matrix is densely packed with enzymes for the Krebs cycle,
except succinate dehydrogenase (complex II) which is associated with the inner
mitochondrial membrane. Three molecules of reduced NADH, and one molecule of ATP
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and FADH2 are produced from the oxidation of acetyl-CoA and two molecules of C02
are released.

The electrons from these energy rich molecules are transferred to oxygen

through the ETC, which releases energy. During the transfer of electrons from higher
energy compounds to lower energy centers, complex I, complex III and complex IV
pump protons from the matrix to the intermembrane space generating an electrochemical
gradient across the inner membrane (Mitchell 196 1).
Mitochondria are semiautonomous cell organelles that contain their own DNA
(mtDNA). There are 92 different genes encoding various subunits of the respiratory
complexes and ATP synthase proteins in the nuclear DNA and mtDNA. In total, 13
respiratory complexes and ATP synthase proteins subunits, two genes for mitochondrial
ribosomal RNAs (mt-rRNA) and 22 mitochondrial transfer RNAs (tRNA) are coded in
mtDNA. The remaining proteins that are essential for proper mitochondrial function are
encoded by nuclear DNA. For instance, Complex II is exclusively encoded by nuclear
DNA (Koopman et al., 20 13, Reinecke et al., 2009, Smeitink et al., 200 1).

MitoNEET (CISDl)
Background
MitoNEET was discovered as the target protein of anti-diabetic drug pioglitazone
(Colca et al., 2004). Localized primarily to the outer membrane of the mitochondria,
mitoNEET is an iron-sulfur cluster protein that is postulated regulates cellular metabolic
homeostasis such as mitochondrial iron homeostasis, electron transport and oxidative
phosphorylation (OXPHOS) (Tamir et al., 20 14, Sohn et al., 20 13, Wiley et al., 2007).
While the exact cellular function(s) of mitoNEET is/are unknown, regulating redox
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reactions in the mitochondria, the accumulation of reactive oxygen species, and control of
apoptosis are a few of the proposed functions (Geldenhuys et al., 2014). Reduced
mitoNEET levels are associated with enhanced mitochondrial iron content, increased
respiration, and reduced weight gain in mice on high fat diets. Increased oxidative stress
and glucose intolerance are associated with reduced levels of mitoNEET (Kusminski et
al., 2012).
Structure of mitoNEET
The protein mitoNEET contains a redox-active iron-sulfur ([2Fe-2S]) cluster in a
CDGSH binding domain. The term "mitoNEET" was given based on its close association
with the mitochondrion (mito) and its conserved amino acid sequence Asn-Glu-Glu-Thr
(NEET) (Colca et al. 2004). MitoNEET is a small protein composed of only 108 amino
acid residues with a molecular weight of 12.2 kDa. The theoretical isoelectric point (pl) is
9.20 (ExPASy 2015) MitoNEET contains 12 negatively charged residues (Aspartic acid
and Glutamic acid) and 17 positively charged residues (Arginine and Lysine).

The

computed instability index (II) of 40.55 indicates mitoNEET is an unstable protein, which
is also supported by the estimated half-life time of 30 hours (for mammalian
reticulocytes), >20 hours (for yeast, in vivo) and >10 hours in vivo (for Escherichia coli,
expressed heterologously) (ExPASy 2015). MitoNEET belongs to the CISD (CDGSH
iron-sulfur domains) protein family. MitoNEET is attached to the outer mitochondrial
membrane by a N-terminal hydrophobic transmembrane helix and the C-terminal
hydrophilic CISD domain is facing the cytoplasm (Wiley et al., 2007). The CDGSH
domain is a type of zinc finger domain which binds iron rather than zinc as a redox-active
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2 13
2
[2Fe-2S] cluster. Recent reports have indicate that Zn + and Fe + + compete for the same
Zn-finger motif in mitoNEET (Tan et al. 2012).
In humans, there are three CISD proteins present named mitoNEET (CISDl),
Miner 1 (CISD2) and Miner2 (CISD3) and they are characterized by presence of one or
two CDGSH motifs. CDGSH is a domain of around 40 aa (amino acids 55-93) annotated
as a CDGSH-type zinc finger with a motif containing a highly conserved 17 amino acid
residue consensus sequence WCXCXX(Sff)XXXPWCDG(Sff/A)H], where W and X
are a hydrophobic or any residue, respectively. The function(s) of all CISD proteins are
still ill-defined (Wiely et al 2007, Lin et al 2011). The redox-active 2Fe-2S cluster is pH
labile and is significantly less stable at pH 4.5 and below when compared to pH 7 .0
(Tirrell et al., 2009).
Crystal structures of mitoNEET
The human mitoNEET forms a homodimer in the crystal structure. Each
2 t3
monomer consists of one redox active [2Fe-2S] cluster. Each Fe + + ion in the clusters is
tetrahedral and coordinated with the ligand, a sulfide ion and two amino acid residues,
cysteine and histidine. MitoNEET and other NEET proteins contain two domain
structures, a cap and a cluster-binding domain (Fig. 2). They are formed by the interlock
of each monomer forming a homodimer and their unique folding domain called NEET
fold. Both structural features play vital roles in harboring the redox-active 2Fe-2S cluster
(Nechushtai et al., 2012). Although other configurations are known, the redox active
[2Fe-2S] clusters in CISD proteins might be either ferredoxin or Rieske type
2 t3
configurations. In the ferredoxin configuration, two cysteine sulfur atoms bind to a Fe + +
ion [(Cys)(Cys)FeS2Fe(Cys)(Cys] (Fig. 2).
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2 13
The Rieske-type is characterized by two cysteine sulfur, one Fe + + ion, and the
Nb

atoms

of

two

histidine

(His)(His)FeS2Fe(Cys)(Cys) .

ligands

MitoNEET

has

bind

to

unique

the

other

2 13
Fe + +

ion,

(Cys)(His)FeS2Fe(Cys)(Cys)

configuration where, as in Rieske centers, Nb nitrogen of the histidine binds to the cluster
(Fig. 2) (Dicus et al. 20 1 0).

D

A

B

C77.,

H1

5P,

ClSl

.

47
C

- C44

C39

c

......

sf:ts
Fe

Fe

5�.,._

Hl34

C132

Figure 2. Redox active [2Fe-2S] cluster (Hou et al. 2007). Unlike ferredoxin (B) and
rieske (C), mitoNEET has unique 2Fe-2S cluster bound with three Cys residues and one
His residue (A) , MitoNEET crystal in a dimer (Lin et al. 20 1 1 ) . Each monomer (dark and
gray) consists of p -P-u-P (C to N terminal) topology and a Zn-finger loop binding an
Iron ion and Sulfur ligand (dark circle) . The respective P-sheets of two monomers are
anti-parallel to each other (D)
The amino acid residues in the C-terminal part up to Lys-55 form

a

P-P-u-P

topology (Figure 2). Ho wever the N-terminal part from Arg-33 to Lys-55 fom1s a long
,

loop. The loop between P2 and al binds a [2Fe-2S] cluster and is flanked by the a-helix
and two anti- p arallel

�-sheets (�2 and P3)

(Fig. 2) . The Pl region consists of hydrophobic
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amino acid residues such as Ile-56, Phe-60, Ala-69, Tyr-71, Phe-80, and Phe-82. The
hydrophobic residues interact with the cluster-binding domain (residues from P2 to P3)
(Hou et al. 2007).
A very tight dimerization is created by the multi-hydrophobic interaction between
different residues of the two associated monomers. (Hou et al. 2007) The amino acid
residues participating in the dimerization are Val-56 and Val-57 from p l, Leu-65 from
loop between P l and p2, Tyr-71 from p2, Trp-75 from the loop between P2 and al, Leu101 and Ile-103 from p3. The hydrophobic residues contribute to the dimerization of
mitoNEET that covers 30% of the total surface area in each monomer. Around 58% of
amino acid residues participate in the dimerization process. During dimerization, the p1
strand of the first monomer, residing in the N-terminal end, forms a parallel P-sheet with
the P3 strand of second monomer resulting in a "face to face" arrangement of two
symmetric 3-stranded beta-sheets (Hou et al. 2007).
Crystal structure of related proteins
The protein At5g51720 (Arabidopsis thaliana) when truncated from amino acid
39 to 108 has biochemical and biophysical properties comparable with human mitoNEET
such as color, absorption peaks in the visible range (at 458 and 530 nm), shift in peaks
after reduction (at 440 and 550 nm), etc..
various

identical

The high level of sequence similarity and

biochemical and biophysical properties of At5 g5 l 720 protein

demonstrate the occurrence of NEET proteins in plants (Nechushtai et al. 2012). In
addition, At5g51720 contains the mitoNEET type of 2Fe-2S cluster, coordinated by a
(Cys)(His)FeS2Fe(Cys)2 ligand, in the CDGSH domain. However, unlike the N-terminal
transit sequence in human mitoNEET, At5 g5 l720 contains a cleavable N-terminal leader
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sequence for the stroma of chloroplast and the mitochondria. The peptide cleavage site of
At5g51720 transit for chloroplast is V-[R/K]!A-E (Su et al. 2013).

Thesis Objective
Recent studies show that mitoNEET plays an important role in mitochondrial
respiration, but little is known regarding the impact of different levels of mitoNEET on
cellular respiration, cell proliferation rate and cellular energy transduction. The purpose
of this study was to elucidate probable role of mitoNEET in liver cancer cells (HepG2
cells) and its ligand pioglitazone on galactose-induced alteration in cellular bioenergetics.

9

LITERATURE CITED
Abbrescia, D. I., La Piana, G., & Lofrumento, N. E. (2012). Malate-aspartate shuttle and
exogenous NADH/cytochrome c electron transport pathway as two independent
cytosolic reducing equivalent transfer systems. Archives of Biochemistry and
Biophysics, 518(2), 157-163.
Borcar, A., Menze, M. A., Toner, M., & Hand, S. C. (2013). Metabolic preconditioning
of mammalian cells: mimetic agents for hypoxia lack fidelity in promoting
phosphorylation of pyruvate dehydrogenase. Cell and Tissue Research, 351(1),
99-106.
Brown, G. C. (1992). Control of respiration and ATP synthesis in mammalian
mitochondria and cells. Biochem. J, 284, 1-13.
Brunmair, B., Staniek, K., Gras, F., Scharf, N., Althaym, A., Clara, R., ... & Flimsinn, C.
(2004). Thiazolidinediones, Like Metformin, Inhibit Respiratory Complex IA
Common

Mechanism

Contributing

to

Their

Antidiabetic

Actions?.

Diabetes, 53(4), 1052-1059.
Colca, J. R., McDonald, W. G., Waldon, D. J., Leone, J. W., Lull, J. M., Bannow, C. A.,
Lund, E. T. & Mathews, W. R. (2004). Identification of a novel mitochondrial
protein

("mitoNEET")

photoprobe. American

cross-linked
Journal

specifically
of

by

a

thiazolidinedione

Physiology-Endocrinology

and

Metabolism, 286(2), E252-E260.
Dicus, M. M., Conlan, A., Nechushtai, R., Jennings, P. A., Paddock, M. L., Britt, R. D.,

& Stoll, S. (2010). Binding of histidine in the (Cys) 3 (His) I-coordinated [2Fe-

10

2S]

cluster

of

human

mitoNEET. Journal

of the

American

Chemical

Society, 132(6), 2037-2049.
Eng, C . , Kiuru, M., Fernandez, M. J . , & Aaltonen, L. A. (2003). A role for mitochondrial
enzymes in inherited neoplasia and beyond. Nature Reviews Cancer, 3(3), 193202.
Fernie, A. R., Carrari, F., & Sweetlove, L. J. (2004). Respiratory metabolism: glycolysis,
the TCA cycle and mitochondrial electron transport. Current Opinion in Plant
Biology, 7(3), 254-261.
Garcia-Ruiz, I., Solis-Munoz, P., Fernandez-Moreira, D., Muiioz-Yagtie, T., & Solfs
Herruzo, J. A. (2013). Pioglitazone leads to an inactivation and disassembly of
complex I of the mitochondrial respiratory chain. BMC Biology,1 1 ( 1 ), 88.
Geldenhuys, W. J., Leeper, T. C., & Carroll, R. T. (2014). MitoNEET as a novel drug
target for mitochondrial dysfunction. Drug Discovery Today, 1 9( 1 0) , 1601-1606.
Halestrap, A. P. (1975). The mitochondrial pyruvate carrier. Kinetics and specificity for
substrates and inhibitors. Biochem. J, 148, 85-96.
Hou, X., Liu, R., Ross, S., Smart, E. J . , Zhu, H., & Gong, W. (2007). Crystallographic
studies of human MitoNEET. Journal of Biological Chemistry,282(46), 3324233246.
http://web.expasy.org/protparam/ retrived on 03/18/2015
Hunter, R. L., Choi, D. Y., Ross, S. A., & Bing, G. (2008). Protective properties afforded
by pioglitazone against intrastriatal LPS in Sprague-Dawley rats. Neuroscience
Letters, 432(3), 198-201.

11

Kaundal, R. K., & Sharma, S. S. (2010). Peroxisome proliferator-activated receptor
gamma agonists as neuroprotective agents. Drug News and Perspectives, 23(4),
241-256.
Knouff, C., & Auwerx, J. (2004). Peroxisome proliferator-activated receptor-y calls for
activation in moderation: lessons from genetics and pharmacology.Endocrine
Reviews, 25(6), 899-918.
Koopman, W. J., Distelmaier, F., Smeitink, J. A., & Willems, P. H. (2013). OXPHOS
mutations and neurodegeneration. The EMBO Journal, 32(1), 9-29.
Kounosu, A., Iwasaki, T., Baba, S., Hayashi-Iwasaki, Y., Oshima, T., & Kumasaka, T.
(2008). Crystallization and preliminary X-ray diffraction studies of the prototypal
homologue of mitoNEET (Tth-NEET0026) from the extreme thermophile
Thermus thermophilus HB8. Acta

Crystallographica Section F:

Structural

Biology and Crystallization Communications, 64(12), 1146-1148.
Kusminski, C. M., Holland, W. L., Sun, K., Park, J., Spurgin, S. B., Lin, Y., Askew, G.
R., Simcox, J. A., McClain, D. A., Li, C., & Scherer, P. E. (2012). MitoNEET
driven alterations in adipocyte mitochondrial activity �eveal a crucial adaptive
process that preserves insulin sensitivity in obesity. Nature Medicine, 18(10),
1539-1549.
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. 0., Willson, T. M., &
Kliewer, S. A. (1995). An antidiabetic thiazolidinedione is a high affinity ligand
for peroxisome proliferator-activated receptor y (PPARy). Journal of Biological
Chemistry, 270(22), 12953-12956.

12

Lemasters, J. J., & Holmuhamedov, E. (2006) . Voltage-dependent anion channel
(VDAC) as mitochondrial govemator-thinking outside the box.Biochimica et
Biophysica Acta (BBA)-Molecular Basis of Disease, 1 762(2), 1 8 1 - 1 90.

Lin, J., Zhang, L., Lai, S., & Ye, K. (20 1 1 ) . Structure and molecular evolution of
CDGSH iron-sulfur domains. PloS One, 6(9), e24790.
McBride, H. M., Neuspiel, M., & Wasiak, S. (2006). Mitochondria: more than just a
powerhouse. Current Biology, 1 6( 1 4), R55 1 -R560.
Mitchell, P. ( 1 96 1 ) . Coupling of phosphorylation to electron and hydrogen transfer by a
chemi-osmotic type of mechanism. Nature, 1 91 (4184), 1 44- 148.
Muller, M., Mentel, M., van Hellemond, J. J., Henze, K., Woehle, C . , Gould, S . B . , . . . &
Martin, W.

F.

(20 1 2) . Biochemistry and evolution of anaerobic energy

metabolism in eukaryotes. Microbiology and Molecular Biology Reviews, 76(2),
444-495 .
Nechushtai, R . , Conlan, A. R . , Harir, Y., Song, L., Yogev, 0., Eisenberg-Domovich, Y . ,
Livnah, 0., Michaeli, D . , Rosen, R . , Ma, V . , Luo, Y., Zuris, J . A . , Paddock, ML. ,
Cabantchik, Z.I. , Jennings, P.A. & Mittler, R. (20 1 2) . Characterization of
Arabidopsis NEET reveals an

ancient role for NEET proteins in iron

metabolism. The Plant Cell Online, 24(5), 2 1 39-2 1 54.
Paddock, M. L., Wiley, S. E., Axelrod, H. L., Cohen, A. E., Roy, M., Abresch, E. C.,
Capraro, D., Murphy, A.N., Nechushtai, R., Dixon, J.E. & Jennings, P. A. (2007).
MitoNEET is a uniquely folded 2Fe-2S outer mitochondrial membrane protein
stabilized

by

pioglitazone. Proceedings

Sciences, 1 04(36), 1 4342- 1 4347 .

13

of

the

National

Academy

of

Patel, M. S . , & Korotchkina, L. G. (2006). Regulation of the pyruvate dehydrogenase
complex. Biochemical Society Transactions, 34(2) , 2 1 7-222.
Prakash, A., & Kumar, A. (20 1 3 ) . Pioglitazone alleviates the mitochondrial apoptotic
pathway

and

mito-oxidative

damage

in

the

d-galactose-induced

mouse

model. Clinical and Experimental Pharmacology and Physiology, 40(9), 644-65 1 .
Rabjljl, R. , Larsen, S . , Hjljj berg, P. M . V., Almdal, T., Boushel, R., Haugaard, S . B . , . . . &
Dela, F. (20 1 0) . Regional anatomic differences in skeletal muscle mitochondrial
respiration in type 2 diabetes and obesity. The Journal of Clinical Endocrinology
& Metabolism, 95(2), 857-863 .

Reddy, P. H., & Reddy, T. P. (20 1 1 ) . Mitochondria as a therapeutic target for aging and
neurodegenerative diseases. Current Alzheimer Research, 8(4), 393 .
Reinecke, F., Smeitink, J. A., & Van Der Westhuizen, F. H. (2009). OXPHOS gene
expression and control in mitochondrial disorders. Biochimica et Biophysica Acta
(BBA)-Molecular Basis of Disease, 1 792( 1 2) , 1 1 1 3- 1 1 2 1 .

Sanz, M . N., Sanchez-Martin, C . , Detaille, D . , Vial, G., Rigoulet, M., El-Mir, M . Y., &
Rodriguez-Villanueva, G. (20 1 1 ) . Acute mitochondrial actions of glitazones on
the liver: a crucial parameter for their antidiabetic properties. Cellular Physiology
and Biochemistry, 28(5), 899.

Scrutton, M. C., & Utter, M. F. ( 1 968). The regulation of glycolysis and gluconeogenesis
in animal tissues. Annual review of biochemistry, 3 7( 1 ), 249-302.
Smeitink, J., van den Heuvel, L. , & DiMauro, S. (200 1 ) . The genetics and pathology of
oxidative phosphorylation. Nature Reviews Genetics, 2(5), 342-352.

14

Sohn, Y. S . , Tamir, S . , Song, L., Michaeli, D . , Matouk, I. , Conlan, A. R., . . . & Mittler, R.
(20 1 3) . NAF- 1 and mitoNEET are central to human breast cancer proliferation by
maintaining

mitochondrial

homeostasis

and

promoting

tumor

growth. Proceedings of the National Academy of Sciences, 1 1 0(36), 1 4676- 1 468 1 .
Song, X. U., Bao, M., Li, D., & Li, Y . M . ( 1 999). Advanced glycation in D-galactose
induced mouse aging model. Mechanisms of Ageing and Development, 1 08(3) ,
239-25 1 .
Su, L. W . , Chang, S . H., Li, M. Y., Huang, H. Y., Jane, W. N., & Yang, J. Y. (20 1 3) .
Purification and biochemical characterization o f Arabidopsis At-NEET, an
ancient iron-sulfur protein, reveals a conserved cleavage motif for subcellular
localization. Plant Science, 213, 46-54.
Tait, S. W., & Green, D. R. (20 10). Mitochondria and cell death: outer membrane
permeabilization and beyond. Nature Reviews Molecular Cell Biology,1 1 (9), 62 1 632.
Tan, G., Landry, A. P., Dai, R., Wang, L. , Lu, J., & Ding, H. (20 1 2) . Competition of zinc
ion for the [2Fe-2S] cluster binding site in the diabetes drug target protein
mitoNEET. Biometals, 25(6), 1 1 77- 1 1 84.
Tirrell, T. F., Paddock, M. L. , Conlan, A. R., Smoll Jr, E. J., Nechushtai, R., Jennings, P.
A., & Kim, J . E. (2009) . Resonance Raman studies of the (His)(Cys) 3 2Fe-2S
cluster of MitoNEET: comparison to the (Cys) 4 mutant and implications of the
effects of pH on the labile metal center. Biochemistry,48(22), 4747-4752.

15

Vander Heiden, M. G., Cantley, L. C . , & Thompson, C . B . (2009) . Understanding the
Warburg

effect:

the

metabolic

requirements

of

cell

proliferation. Science, 324(5930), 1 029- 1 03 3 .
Wallace, D. C . , Fan, W . , & Procaccio, V. (20 1 0) . Mitochondrial energetics and
therapeutics. Annual Review of Pathology, 5, 297 .
Wiley, S . E., Murphy, A. N., Ross, S . A., van der Geer, P., & Dixon, J. E. (2007) .
MitoNEET i s an iron-containing outer mitochondrial membrane protein that
regulates

oxidative

capacity. Proceedings

of

the

National

Academy

of

Sciences, 1 04( 1 3) , 53 1 8-5323 .

Willson, T. M . , Lambert, M. H., & Kliewer, S . A. (200 1 ) . Peroxisome proliferator
activated receptor y and metabolic disease. Annual Review of Biochemistry, 70( 1 ) ,
34 1 -367.
Xu, D., Murakoshi, N., lgarashi, M., Hirayama, A., Ito, Y., Seo, Y., Tada, K. & Aonuma,
K.

(20 1 2) .

PPAR-y Activator Pioglitazone

Prevents

Age-Related

Atrial

Fibrillation Susceptibility by Improving Antioxidant Capacity and Reducing
Apoptosis in a Rat Model. Journal of Cardiovascular Electrophysiology, 23(2),
209-2 1 7 .

16

CHAPTER ONE

D-GALACTOSE DECREASES MITONEET (CISD l ) LEVELS IN HEPG2 CELLS
ABSTRACT

Supra-physiological levels of D-galactose accelerate aging in rodents by
increasing the production of reactive oxygen species (ROS). However, the underlying
mechanism of galactose action is still poorly resolved. Similar to galactose treatment,
mitoNEET deficiency decreases iron content in the mitochondrial matrix and increases
mitochondrial ROS production. MitoNEET is a small iron-sulfur cluster containing
protein localized to mitochondrial membranes and was discovered as a target protein of
the drug pioglitazone. Pioglitazone, an antidiabetic drug, also ameliorates galactose
mediated aging processes, such as memory deficits and decreased motor activities in a
mouse model of aging. To investigate the role(s) of mitoNEET in galactose-induced
aging, we exposed human hepatocellular carcinoma cells (HepG2) to 1 0 mM D-galactose
and measured endogenous mitoNEET levels by immunoblotting. Galactose treatment for
2 weeks significantly reduced mitoNEET levels. This effect was observed both in
presence or absence of glucose in the culture medium. D-galactose also decreased
mitoNEET tagged with green fluorescent protein (mNT-GFP) levels in stably transfected
HepG2 cells under the control of the human cytomegalovirus (CMV) promoter.
Furthermore, treatment of HepG2 cells with 60 µM pioglitazone significantly reduced
mitoNEET levels similar to D-galactose but at low concentration increased protein
concentrations. Since the synthesis of endogenous mitoNEET and mNT-GFP are
regulated by different promoters, D-galactose most likely increases degradation rates of
mitoNEET. Immunoblotting revealed higher mitoNEET levels in synaptosomes isolated
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from aged mice compared to their younger counterparts. This report highlights the links
mitoNEET to a D-galactose induced model of accelerated aging.
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INTRODUCTION
Galactose mediated aging models: Impact of pioglitazone

Peroxisome proliferator-activator receptor gamma (PPARy) is a transcription
factor which include 48 transcription factors.

The activity of PPARy is regulated by

direct binding of lipid metabolites, hormones such as steroid and
thyroid, xenobiotics and vitamins (Kersten et al. , 2000). Several
target genes that PPARy stimulate such as genes encoding
lipoprotein lipase, fatty-acid transport protein, oxidized LDL
receptor 1 play a role in metabolic homeostasis including

D-glucose

increased insulin sensitization and lipid circulation thereby
lowering glucose, differentiation and maturation of adipocytes.
Likewise, PPARy stimulation is associated with increased food
intake in brain and increased antigen uptake in dendritic cells

D-galactose

(Brunmair et al, 2004, Knouff and Auwerx 2004, Willson et al. , 200 1 , Lehmann et al. ,
1 995 and Wiley et al, 2007).
The PPARy agonist thiazolidinedione (TZD) family members, pioglitazone for
example, induce the PPARy coactivator 1 -alpha (PGC- l a) (Hondares et al. , 2006).
Transcriptional co-activators PGC- l a, PGC- l P
and PGC- 1 -related co-activator (PRC) are the
members of PPAR-y coactivators- 1 (PGC- 1 ) .
These co-activators have a vital role in

Pioglitazone

maintaining cellular metabolic activities including carbohydrate and lipid metabolism,
reactive oxygen species homeostasis and energy homeostasis. Furthermore, the
19

antioxidant proteins glutathione-peroxidase (GPX), superoxide dismutase (SOD) and
catalase (CAT) also belong to the PGC- 1 family

(Salem et al. , 20 1 2, Hondares et al. ,

2006). Pioglitazone, a glucose lowering drug in type I I diabetic patients, has been found
to bind mitoNEET (Colca et al. , 2004) as well as reduce mitochondrial activity by
inhibiting complex I activity in liver tissue and skeletal muscle tissue (Garcia-Ruiz et al. ,
20 1 3 , S anz et al. , 20 1 1 , Tait and Green 20 10, Rabf,'Sl et al. , 20 1 0) .
Aging i s characterized b y reduced mitochondrial function, stress intolerance,
decline of anatomical integrity and function of tissue and organ systems. Although, the
mechanism of these processes is still unknown, genetic and environmental factors trigger
aging (Semba et al. , 20 1 0, Sabin 20 1 0) . According to the metabolism theory, aging is the
consequential phenotype of a metabolism disorder of the body (Tang and He 20 1 3) .
Similar to biological aging and various age-related neurodegenerative diseases, long term
exposure of D-galactose induces progressive mitochondrial dysfunctions, and to a decline
in learning and memory capacity in a rodent model (Lei et al. 2008, Song et al. , 1 999) but
the mechanism of this toxicity is unknown.
A reducing sugar such as D-galactose elevates advanced glycation end-products
(AGEs) in animal cells and tissues (Schalkwijk et al. , 2004, Semba et al. , 20 10, Singh et
al. , 200 1 , Song et al. , 1 999) . The carbonyl group of galactose reacts with primary amino
groups of proteins, and due to glycoxidation and auto-oxidation, highly reactive carbonyl
compounds such as carboxymethyl-lysine and hydroimidazolone are formed.

These

reactive carbonyl compounds react with lipids, nucleic acids and proteins forming a
group of heterogeneous macromolecules, the AGEs (Schalkwijk et al. , 2004, Singh et al. ,
200 1 ) . An elevation o f AGEs levels in cells i s responsible for a significant glucose
20

metabolism disorder, increase in reactive oxygen species (ROS) and thereby causing
abnormal metabolism of tissues and organs including heart, liver, kidney, brain and other
important organs. Furthermore, galactose is reduced into galactitol and increases lipid
peroxidation, damage cell membranes leading to an acceleration of aging (Semba et al. ,
20 10, Song et al. , 1 999) . Therefore, galactose has been used as a tool to study accelerated
aging, oxidative stress, and tissue damage in animal models (Tang and He 20 1 3 ,
Parameshwaran et al. , 20 1 0, Song et
al. , 1 999) .
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rodent model (Prakash and Kumar
20 1 3 , Hunter et al. , 2008). To investigate the involvement of mitoNEET in aging
processes, we measured mitoNEET levels in HepG2 cells exposed to galactose and in
synaptosomes isolated from young and old mice brains.
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METHODS
Chemicals

All chemicals for respiration measurements were purchased from Sigma-Aldrich
(St. Louis, MO) or Fisher Scientific (Fair Lawn, NJ) . Water for solution preparation was
purified with a Milli-Q Reagent Water System (Billerica, MA) to an electrical resistance
of 1 8 mn.
Cell Culture

Human hepatocellular carcinoma cells (HepG2) were obtained from the American
2
Type Culture Collection (Manassas, VA) and grown in 75 cm cell culture flasks
(Coming Incorporated, Coming, NY) . Standard cell culture medium was composed of
Opti-MEM I reduced serum medium (lnvitrogen, Carlsbad, CA) supplemented with 5 . 5 %
fetal bovine serum (FBS) purchased from Atlanta Biologicals Inc. (Flowery Branch, GA),
1 00 units/ml penicillin, 1 00 µg/ml streptomycin, and 250 ng/ml amphotericin B (MP
Biomedicals, Santa Anna, CA) . Treatment groups were switched to DMEM (Dulbecco's
Modified Eagle Medium) supplemented with 10 mM D-galactose, 1 5 mM glucose, and
both 1 0 mM D-galactose and 1 5 mM galactose at least two weeks prior to
experimentation. Dialyzed FBS was used for 0 mM glucose treatment. The cells were
maintained in a humidified atmosphere of 6.5 % C02 and 93 .5% air at 37 °C and the
culture medium was renewed every 3-4 days. The cells were sub-cultured every seven
days or before reaching -90% confluency. To sub-culture, cells were dissociated using
0.25% trypsin plus 1 mM EDTA in balanced salt solution (lnvitrogen, Carlsbad, CA) and
2
reseeded at 1 .5 x 1 0 6 cells per 75 cm cell culture flasks.
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Cloning, transfections and generation of stable cell lines

pCMV6-AC-GFP (RC203 308Ll ) (OriGene Technologies, Inc, Rockville, MD
20850) vector was used to generate green fluorescent protein tagged mitoNEET cell lines
(HepG2-mNT-GFP) . The protocol for transfection of HepG2 cells grown in 2500 µL of
®
medium in 35 mm dishes using a FuGENE HD:DNA ration of 4.5: 1 was followed to
generate the cell line. Briefly, HepG2 cells were plated a day prior to transfection at a
density of 80% per well in a 35 mm dish in 2 ml of complete growth medium (DMEM +
1 0% FBS). DNA solution at the concentration of 2.5 µg per well was added after mixing
®
DNA and reagent (FuGENE HD) at the ratio of 4.5:1 in 1 25 µL of medium. The
transfected cells were selected using neomycin (G4 1 8).
Impact of galactose and glucose on mitoNEET levels

SDS-PAGE and Western blotting techniques were used to study the impact of
galactose and glucose on mitoNEET levels. Proteins isolated from HepG2 cells and
HepG2-mNT-GFP cells cultured in DMEM supplemented with D-galactose, D-galactose
with dialyzed FBS , glucose and both galactose and glucose were used. Proteins were
isolated from -5x 1 06 cells of the respective treatment groups using RIPA buffer (25mM
Tris-HCI pH 7 .6, 1 50mM NaCl, 1 % NP-40, 1 % sodium deoxycholate, 0. 1 % SDS)
following the manufacturer' s protocol (Thermoscientific # 89900) and the protein
concentration was determined using Thermo Scientific, Pierce™ Coomassie (Bradford)
Protein Assay Kit according to the instructions of the manufacturer (Thermo Fisher
Scientific, Waltham, MA) .
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Synaptosome Isolation from mouse brain

Brain synaptosomes from young (3-6 months) and old ( 1 2+ months) female WT
(C57BU6J) littermate mice were used in this study. S ynaptosomes were isolated by Eric
Hendricks for his thesis work as described by Kristian (20 1 0) with minor modification
and kindly provided to us (Hendricks 20 1 5 , Master' s Thesis) . Briefly, the forebrain was
removed, washed, and homogenized in 20 mL of isolation medium (IM) containing
sucrose (225 mM), mannitol (75 mM), EGTA ( 1 mM), HEPES (5 mM), and 1 g/L BSA
adjusted to pH 7.4 with Tris base. The homogenate was transferred evenly into two 1 0
mL polycarbonate tubes and centrifuged at 1 300g for 3 min. The pellet was resuspended
in 3 mL of IM and centrifuged at 1 300g for an additional 3 min. The supernatants from
the two centrifugations were combined and centrifuged at 2 1 ,000g for 1 0 min. A Percoll
gradient in IM was prepared in a separate polycarbonate tube by first adding 3 .7 mL of
24% Percoll and, using a transfer pipette, 1 .5 mL of 40% Percoll was slowly added
underneath the 24% Percoll layer. The supernatant from the previous centrifugation step
was discarded and the pellet was re-suspended in 3 .5 mL of 1 5 % Percoll, and the re
suspended pellet was next layered on top of the 24/40% Percoll gradient using a transfer
pipette, and then centrifuged at 30,700g for 8 min. The material at the 1 5 % Percoll band,
containing mostly myelin, was discarded, whereas the 24% Percoll band, containing
mostly synaptic mitochondria, was collected. The fraction containing the synaptosomes
was washed with 6 mL of IM and centrifuged at 1 6, 700g for 1 0 min. This step was
repeated and the supernatant was discarded both times . The resulting pellet was re
suspended in 400 µL of IM and contained 6-7mg/mL synaptosomal protein, which was
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determined using a Percoll friendly Modified Lowry Protein Assay Kit according to the
instructions of the manufacturer (Thermo Fisher Scientific, Waltham, MA).
SDS-PAGE and Western blot analyses.

Isolated proteins were subjected to 12% SDS-PAGE using a Bio-Rad Mini
PROTEAN 3 Cell (Bio-Rad Laboratories, Hercules, CA). Proteins were denatured at
96°C for 5 min in sample buffer (2% SDS , 25 % glycerol, 5 % P-mercaptoethanol, 0.0 1 %
bromphenol blue, and 62.5 mM Tris-HCl, pH 6.8), and 1 5-20 µ g of protein were loaded
per lane. After electrophoresis, proteins in the gel were electrophoretically transferred
onto a nitrocellulose membrane (0.2 mm, Bio-Rad) in a transfer buffer ( 1 92 mM glycine,
20% methanol, 0.025 % SDS, and 25 mM Tris) by use of a Bio-Rad Mini Trans-Blot.
Membranes were stained with Ponceau S (Sigma-Aldrich 0. 1 % v/v glacial acetic acid,
0.0 1 1 % w/v Ponceau S) to confirm transfer of the proteins . The nitrocellulose membrane
was blocked using blocking buffer (5 % w/v milk powder in TBS -T, 20 mM Tris-HCl, pH
7 .6, 1 37 mM NaCl and 0. 1 % Tween-20) for 1 hour.

Anti-CISD l [2B 3] mouse

monoclonal antibody (ab 1 1 8027), rabbit polyclonal antibodies anti-VDAC antibody (Cell
Signaling, #D73 1 2) , anti- P-tubulin (Cell Signaling, #2 1 28S) and anti-P-actin antibody
(Cell Signaling, #4967S ) were used as primary antibodies at 1 : 5 ,000 dilutions. The blots
were incubated overnight with the primary antibody in blocking buffer at 4 °C.
Biotinylated goat anti-rabbit IgG and goat anti-mouse IgG (Vector Laboratories) were
used as secondary antibodies at dilutions of 1 : 5 ,000. Blots were stained and developed
using Amersham Hyperfilm™

(GE healthcare Ltd, #28906837) and LumiGLO (Cell

Signaling Technology, Danvers, MA #7003) , following the protocol of the manufacturer.
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Western Blotting band analysis

ImageJ (imagej .nih.gov/ij/ National Institutes of Health) open access software
was used to analyze the band intensities. The bands intensities were expressed in terms of
percentage of a cellular housekeeper and/or a mitochondrial housekeeper protein (P
tubulin, P-actin and/or VDAC).
Statistical Analysis

Student t-test using Microsoft excel was used to analyze Western blot data. A
stepwise multiple

comparisons procedure

(Newman-Keuls

method)

identify sample means that are significantly different from each other.
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was

used

to

RESULTS
D-galactose decreased cellular mitoNEET levels in HepG2 cells

HepG2 cells were grown in DMEM supplemented with 1 0 mM galactose for two
weeks . The two proteins P-actin and VDAC were chosen as cellular and mitochondrial
housekeeper proteins, respectively. Western blotting showed

galactose treatment

significantly reduced mitoNEET levels to 29 .4 ± 2. 1 6 % of p actin from 42.73 ± 4.28 %
of p actin in high glucose medium (Fig. 4). To investigate whether galactose or glucose is
responsible for the altered levels of mitoNEET, we used a low glucose medium and
supplemented with 1 5 mM glucose alone, 1 0 mM galactose alone or the combination of
1 5 mM glucose plus 1 0 mM galactose. Western blotting showed galactose decreased the
mitoNEET levels irrespective of presence of the glucose and band intensities of 45 . 8 ±
5 . 3 5 % of controls were found in samples cultured in 1 0 mM galactose alone, 72.6 ± 4.37
% of controls in 15 mM glucose and 10 mM galactose together (Fig. 5). No changes in
the amount of VDAC or P-actin (Fig. 4 and Fig. 5 ) were found among the treatment
groups verifying that both proteins are suited to serve as housekeeper proteins .
Furthermore,

the results

support the

interpretation that mitoNEET levels

per

mitochondrion were decreased due to galactose treatment and not as a result of reductions
in mitochondrial quantity per cell.
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()

D-galactose likely targets degradation of cellular mitoNEET in HepG2 cells

The synthesis of cellular mitoNEET is endogenously regulated by cisdl gene
located on chromosome 1 0 (Tamir et al. , 20 1 5 , http://www.ncbi.nlm.nih.gov/gene/55 847)
HepG2 cells were stably transfected with a chimeric protein composed of green
fluorescent protein (GFP) attached to the C-terminus of mitoNEET (mNT-GFP).
Transcription of the construct was under the control of the human cytomegalovirus virus
(CMV) promotor. After stable clones were obtained, the mNT-GFP cells were cultured in
low glucose medium supplemented with 1 0 mM D-galactose for two weeks . Similar to
the levels of endogenous mitoNEET in control HepG2 cells (Fig. 5 ) , the galactose
treatment significantly reduced the endogenous mitoNEET levels to 75.2 ± 2.4 % of
controls in GFP-mNT-GFP cells. Surprisingly, not only were the endogenous mitoNEET
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medium. Galactose reduced both endogenous as well as mNT-GFP.
were quantified using ImageJ software (p

<

0.05 ,
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n =

3, ± SEM).

Band intensities

levels reduced, but galactose also lowered the levels the chimeric protein mNT-GFP to
52.7 ± 9 . 3 9 % of controls (Fig. 6), suggesting that galactose increases degradation rates
of mitoNEET.
Time course of mitoNEET degradation

HepG2 cells maintained in high glucose medium were transferred to the medium

-

supplemented with 1 0 mM D-galactose and the levels of endogenous mitoNEET were
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Figure 7 : D-galactose mediated degradation of mitoNEET increases over time.

(A)

Western blot showing mitoNEET levels in HepG2 cells after switching the medium
glucose to galactose (B) B and intensities were quantified using ImageJ software (p

<

0.05 , mean ± SEM), curve is only for the illustration purpose.
measured every other day for two weeks . Western blotting shows galactose significantly
reduced endogenous mitoNEE T levels in two w eeks compared to the controls (Fig. 7) .
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Pioglitazone at high concentration reduces but at low concentration partially
restores mitoNEET

HepG2 cells cultured in high glucose medium or in presence of 1 0 mM galactose
supplemented medium were treated with different concentration of pioglitazone for 24 h.
Again, � actin and VDAC were used as cellular housekeeper and mitochondrial
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Figure 8. Pioglitazone reduces mitoNEET levels at high concentrations, but restores
protein levels at low concentrations . Western blot showing mitoNEET levels in
HepG2 cells treated with different concentration of pioglitazone (pio) cultured in (A)
1 0 mM galactose and (B) high glucose medium. Band intensities were quantified
using ImageJ software.
housekeeper proteins, respectively. Western blotting revealed pioglitazone at a
concentration of 60 µM s ignifi cantly reduc ed en do genous mitoNEET levels similar to
D-galactose but at 7 .5 µM and 1 5 µM p arti al ly restored endogenous mitoNEET levels in

both high gluco s e and g a lacto se supplemented mediums (Fig. 8).
MitoNEET expression i s elevated i n the synaptosomes o f aged mice
S ynaptosomes

(mitochondria located in n eurona l cell tenninals) were i s ol ated

from the forebrain of young (3-4 month old) and old (more than 1 2 months old) mice.
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The endogenous mitoNEET levels were measured using the Western blotting technique.
Two proteins which are synthesized regularly in the cells W-actin and �-tubulin) were
used as control for cellular housekeeping proteins and the outer mitochondrial protein
VDAC, served as control for a mitochondrial housekeeping protein. Western blotting
showed significant increases in endogenous mitoNEET levels in aged mice compared to
the young counterparts (Fig. 9).
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Figure 9. Old mice express higher mitoNEET levels in brain. (A) Western blot showing
mitoNEET levels in synaptosomes of young and old mice. (B) Band intensities were
quantified using ImageJ software (p
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0 . 0 5 , young

n =

4, old n
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3,

±

SEM) .

* statistically significant differences between young and old group of mice.
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DISCUSSION

The results of this study document that exposure of HepG2 cells to galactose
decreased endogenous mitoNEET levels and the level of the chimeric protein mNT-GFP.
Furthermore, treatment of hepatocytes with pioglitazone, which binds to mitoNEET, also
reduced endogenous mitoNEET levels at high concentration but restored galactose
induced reductions in endogenous mitoNEET levels at low concentration.
Recent studies suggest that, similar to mitoNEET knockdown experiments,
chronic administration of galactose facilitates the aging process by increasing oxidative
stress, mitochondrial injury and advanced glycation end products (AGE) in vivo
(Parameshwaran et al. , 20 1 0, Semba et al. , 20 1 0, Song et al. , 1 999) . Decreases in
mitoNEET levels in HepG2 cells cultured in D-galactose (Fig. 5) might be an example of
glycation and degradation or a feedback mechanism to control increased mitochondrial
activity due to relief of the Crabtree effect (see Chapter 2) (Crabtree 1929). Pioglitazone
partially restored mitoNEET levels (Fig. 8), perhaps by inducing PGC l a expression and
counteracting galactose-induced increased respiration by inhibiting complex I and
playing a protective role against galactose-induced aging observed in a rodent model
(Prakash and Kumar 20 1 3 , Kaundal and Sharma 20 10, Hunter et al. , 2008). Pioglitazone
also plays a protective role against D-galactose-induced mitochondrial oxidative damage
and apoptosis through activation of nuclear transcription factor PPARy receptors
(Prakash and Kumar 20 1 3) . Increased ROS

production,

oxidative damage and

mitochondrial dysfunction are the characteristic features of aging. We observed
synaptosomes isolated from aged group of mice have higher mitoNEET levels (Fig. 9).
Overexpression of mitoNEET

might be
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the

positive

feedback

mechanism

of

overexpressed PGC l a to reduce progressively increased ROS levels down thereby
protecting cells and organelles.
In conclusion, results suggest that mitoNEET plays a role in biological as well as
galactose increased aging, which may be due to decreased mitoNEET levels thereby
increasing ROS levels in the cells. Increases in ROS levels as a results of mitoNEET
knockdown and galactose treatment should be evaluated in a rodent model using liver
tissues or in the HepG2 cell model. Pioglitazone partially restored galactose induced
decreases in mitoNEET levels and perhaps suggests that this might ameliorate galactose
toxicity in the cells . Biological aging and galactose induced aging likely utilize distinct
mechanisms in terms of mitoNEET effects.
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CHAPTER TWO

THE EFFECTS OF PIOGLITAZONE ON LIVER CELL BIOENERGETICS
ABSTRACT

Insulin resistance is linked to mitochondrial dysfunction and decreased oxidative
capacity of metabolically active tissues. Pioglitazone is commonly used to treat type-II
diabetes and has been shown to interact with mitoNEET {mNT, CISD l ) which localizes
to the mitochondrion. We recently observed that human hepatocellular carcinoma cells
(HepG2) cultured in presence of D-galactose ( 1 0 mM) at low glucose concentrations (< l

mM) express significantly reduced levels of mitoNEET compared to cells cultured in
presence of glucose alone. We hypothesized that since galactose and pioglitazone alter
cellular mitoNEET levels, significant changes in cellular bioenergetics may occur. We
employed respirometry and calorimetry to investigate the effects of mitoNEET levels on
cellular bioenergetics after galactose and pioglitazone treatment in HepG2 cells.
Respiration rates of permeabilized cells in the presence of mitochondrial substrates
(malate, glutamate plus pyruvate) utilized by complex I and ADP (OXPHOS ) were
1
significantly increased for HepG2 cells cultured in galactose (45 . 8 ± 1 .96 pmol 02 . s1 0-6 cells ; n
pmol 02

·

6, ± SE) compared to cells cultured in 1 5 mM glucose alone (30.5 ± 2.94

=

s-

•

1

·

1 0-6 cells ; n

=

6, ± SE) . Acute exposure to 60 µM pioglitazone caused a

severe reduction in OXPHOS for cells cultured in either medium (galactose: 1 2. 1 8 ± 1 .37
pmol 02

·

s-

1

•

1 0-6 cells ; glucose: 10. 1 ± 1 .0 1 pmol 02

·

s-

1

•

1 0-6 cells) .

Overall heat flow of intact cells was -55 .6 ± 3 .0 µW per million cells in glucose
medium and metabolic activity was significantly reduced to -47 .2 ± 2.5 µW per million
cells (n

=

10, ± SE) in cells cultured in the presence of galactose. Surprisingly, acute
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treatment of cells with 60 µM pioglitazone increased heat dissipation in cells grown in
glucose medium by -20%, but the effect was significantly lower for cells cultured in the
presence of galactose. Transfection of HepG2 cells with green fluorescent protein tagged
mitoNEET (HepG2-GFP-mNT) increased respiration rates and heat flow in either
glucose or galactose media. Our results demonstrate that pioglitazone targets complex I
of the mitochondrial OXPHOS machinery, but the decrease in mitochondrial efficiency is
likely compensated by an increase in glycolytic flux.
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INTRODUCTION

Diabetes related complications are the primary cause of death in the USA. In
20 1 2, 29. 1 million Americans or 9 . 3 % of the total population have been diagnosed with
type II diabetes. Even more strikingly, 1 1 . 8 million or 25 .9% of elderly people above the
age of 65 years have diabetes (National Diabetes Statistics Report, 20 1 4) . The American
Diabetes Association (ADA) states that diabetes caused 23 1 ,404 deaths as listed on the
death certificates in 20 1 3 (ADA). Pioglitazone (brand name 'Actos ' ) , PPARy agonist, is
used to increase the response of cells to the blood-sugar regulating hormone insulin
(peripheral tissue insulin sensitivity), and to inhibit the release of blood sugar (glucose)
from the liver in type-2 diabetes (Miyazaki 2002). Recent studies demonstrated that
pioglitazone also binds to mitoNEET and addresses the underlying cause of type-2
diabetes through increasing deposition of fat (lipids) in fat cells termed adipocytes
(Kusminski et al. , 20 1 2 , Colca et al. , 2004) .
The biological function(s) of mitoNEET are still unknown, but the proposed
functions include donation of the iron-sulfur cluster to unknown acceptor protein(s) and
functioning as electron transfer protein. Regulation of redox reactions and oxidative
phosphorylation (OXPHOS) in the mitochondria, accumulation of reactive oxygen
species (ROS) and control of apoptosis are also the proposed functions of mitoNEET
(Tait and Green 20 1 0, Wiley et al. , 2007, Kaundal and Sharma 20 1 0) . Transfer of unique
iron-sulfur cluster of mitoNEET is decisive for mitoNEET functioning (Tamir et al. ,
20 14, Wiley et al. , 2007) . Binding of pioglitazone to mitoNEET has been shown to
reduce the likelihood of iron-sulfur cluster transfer in vitro (Paddock et al. , 2007, Wiley
et al. , 2007) . High mitoNEET levels are associated with enhanced mitochondrial iron
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content, increased respiration rates and reduced weight gain on high fat diet in a mouse
model of obesity. Similarly, increased oxidative stress and glucose intolerance are
associated with reduced level of mitoNEET (Kusminski et al. , 20 1 2) .
The maj or function o f mitochondria is to generate and supply ATP to the cells i n addition
to supplying intermediates for several biosynthetic pathways. Furthermore, mitochondria
are the major producers of cellular ROS . Compromised energy metabolism and
mitochondrial dysfunction are characteristic features of metabolic diseases like diabetes
(Kim et al. , 2008), and neurodegenerative diseases including Alzheimer' s disease and
Parkinson' s disease (Swerdlow 2009).
The efficiency of mitochondrial OXPHOS can be defined as the ratio of ATP
generated per amount of oxygen consumed (PIO ratio) . A high PIO ratio indicates better
coupling of the electron transport system (ETS) with the phosphorylation system.
Decreases in the proton motive force (8p) and increased uncoupling of the OXPHOS
system leads to waste of redox energy and increases in thermogenesis. Unspecific proton
leak (LEAK respiration), fatty acids, uncoupling proteins (UCP), calcium uniport,
4
adenine nucleotide antiport (ADP/ATP exchange), phosphate symport (P0 -/H+ uptake),
and aspartate/glutamate + H+ exchange are the major mitochondrial membrane potential
(8\}Im) consuming processes across the mitochondrial membrane (Kadenbach 2003)
Experimentally, the state of oxygen consumption by isolated mitochondria after addition
of different substrate are traditionally categorized into five states, designated 1 through 5 .
State 1 i s the respiration of mitochondria alone (in presence of Pi) and State 2 includes
the addition of ADP without exogenous substrate. State 3 includes the ADP-stimulated
oxygen consumption by intact mitochondria in presence of excess substrate (OXPHOS)
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respiration and state 4 is carried out in presence of specific mitochondrial substrate
(malate, glutamate plus pyruvate, succinate and fatty acids) but without ADP or any
metabolic inhibitors (LEAK) . Lastly, state 5 is the respiration without oxygen.

Only

respirations states 3 and 4 are frequently used when measuring the efficiency of
mitochondrial OXPHOS . State 3 respiration in presence of substrate plus ADP is often
denoted by state 3 ADP and in presence of uncoupling reagent is denoted by state 3u
(Nicholls and Ferguson 20 1 3) .
The respiration i n response to ADP measures the ability o f mitochondria to
synthesize ATP and is represented by the mitochondrial respiratory control ratio (RCR) .
The RCR, the proton leak rate (LEAK), the maximum respiratory rate, and the coupling
efficiency all provide information about mitochondrial function and dysfunction (Brand
and Nicholls 20 1 1 ) . The ratio of state 3/state 4 respiration is known as the RCR. RCR is
not an absolute value, but depends on the tissue type and substrate. A high RCR value
indicates better membrane integrity, greater capacity for oxidation of substrate and high
efficiency in ATP production. State 3 respiration rates depend on the size of cytochrome
c-ubiquinone (cyt c-UQ) pool, and concentration of available oxygen, whereas proton
leak and A TPase contamination primarily control state 4 respiration (Nicholls and
Ferguson 20 1 3) . Oligomycin A inhibits the ATP synthase (Salomon et al. , 2000).
Therefore, a high state 4 respiration rate after addition of oligomycin (state 4o) indicates
high proton leak in vivo or injury to the inner mitochondrial membrane during the
isolation process. A low state 4o indicates high proton motive force (PMF) sufficient
enough to restrict electron transport (Brand and Nicholls 20 1 1 ) . PMF (.!\p) is defined as a
proton circuit across the inner mitochondrial membrane created by proton pumps of ETS
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together with ATP synthase. This energetic force or potential is central to mitochondrial
bioenergetics which has two components, pH gradient and the membrane potential
(8.'l'm) between mitochondrial matrix and cytoplasm (eqn 1 ) (Brand and Nicholls 20 1 1 ,
Nicholls and Ferguson 20 1 3) .
8.p

=

L\'l'm - 6 1 .5 log l OL\.pH

(Equation 1 )

Warburg effect and Crabtree effect

Glucose is a major source of cellular energy. When the cell has an adequate
supply of metabolic energy available in the form of ATP, the breakdown of glucose is
inhibited because NADH, generated in the Kreb ' s cycle, inhibits isocitrate dehydrogenase
(EC 1 . 1 . 1 .4 1 ) and a-ketoglutarate dehydrogenase (EC 1 .2.4.2), thus accumulating acetyl
CoA and lactic acid (Berg et al. , 2002) . An important aspect of cancer cells is their ability
to survive under hypoxic and acidic conditions (Marroquin et al. , 2007). Many highly
proliferative cells, including cancerous cells, depend on glycolysis for ATP generation
despite the abundance of oxygen and fully functional mitochondria (Warburg effect),
likely to increase production of precursors for biosynthetic pathways (Heiden et al.,
2009).

However, despite the reduction in cellular respiration the mitochondria are not

impaired, they are just not utilized; this phenomenon was first identified by Otto Warburg
and was termed the Warburg Effect (Warburg 1 956, Vander et al. , 2009).
The phenomenon that some cells, in spite of having fully functional mitochondria
and abundant oxygen, shift metabolism towards glycolysis in presence of high glucose
concentrations, is known as the Crabtree Effect (Marroquin et al. , 2007, Crabtree 1 929) .
When using immortalized cell lines (cancer cells) as a model to evaluate mitochondrial
function, it is important to understand the consequences of the Warburg and Crabtree
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effects. Many mitochondrial toxicants cannot be detected with this cellular model due to
limited use of the mitochondria in immortalized cells (Vander et al. , 2009). However,
some immortalized cell when grown in galactose medium in the absence of glucose favor
mitochondrial respiration (OXPHOS ) due to relief from the Crabtree effect (Altamirano
et al. , 2006) . To elucidate the role of mitoNEET in galactose and pioglitazone induced
changes in liver cell bioenergetics, we used cellular respirometry and calorimetry.
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METHODS

Respirometry of HepG2 cells

6
Respiration was measured at 37 °C using l x l 0 cells per mL in each chamber of
the Oxygraph-2K (OROBOROS Instruments, Innsbruck, Austria) . Oxygen consumption
of permeabilized cells was measured in 2 mL of MiR05 ( 1 1 0 mM sucrose, 60 mM
potassium lactobionate, 20 mM taurine, 1 0 mM KH2P04 , 3 mM MgCh, 0.5 mM EGTA,
0. 1 % BSA, 20 mM HEPES-KOH, pH 7 . 1 ) . In order to supply mitochondrial substrates,
cells were permeabilized by the addition of digitonin dissolved in Me2SO at 1 0 mg • mL-

1

(final concentration 1 0 µg • 1 0-6 cells) . This digitonin concentration was found to be
sufficient to permeabilize the plasma membrane of HepG2 cells with low impact on the
integrity of the outer mitochondrial membrane. Electron flow through complex I was
stimulated by adding 2 mM malate, 1 0 mM glutamate, and 5 mM pyruvate (MGP) . To
engage the phosphorylation system, 1 mM ADP was added followed by the addition of
1 0 mM succinate to supply electrons to the ubiquinone pool via succinate dehydrogenase.
Leak respiration in presence of ADP and ATP was measured after addition of oligomycin
1
(2 µg • mL- ), and contribution of complex I to leak respiration was recorded after
addition of rotenone (0.5 µM) . Non-mitochondrial oxygen consumption was recorded
after addition of 2.5 µM of antimycin A. Oxygen consumption was measured with an
Oxygraph-2K (OROBOROS Instruments, Innsbruck, Austria) DATLAB software
(OROBOROS Instruments) was used for data analysis and acquisition.
Heat Dissipation

An LKB 2277 thermal activity monitor (Bromma, Sweden) was used to measure
the heat dissipation of cells in suspension. Static and dynamic calibrations against water
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in both ampoules were performed before the heat signal was measured. For the biological
experiments, water in the sample ampoule was replaced with 2.5 ml of cell suspension.
One ampule was set as the control (DMSO) while the other ampule had 60 µM
pioglitazone. This total suspension contained between 375 ,000 and 5 00,000 cells in
culture medium equilibrated with 1 0% C02 and 90% air. All calorimetric measurements
were performed at 37 °C. Overall heat flow of intact cells was recorded for 2 hours after
the ampoule was lowered into the calorimeter.
Cell proliferation

The cells were maintained in a humidified atmosphere of 6.5% C02 and 93 .5% air
at 37 °C. Cells that were used for proliferation data were also incubated in 1 5 , 30, or 60
µM pioglitazone. To assess the cell proliferation rates, 250,000 cells per well were plated
on a 1 2-well plate. Different concentrations of pioglitazone were added (0-60µM) after
24 h that cells were plated. Cells were counted after 24 and 48 h after pioglitazone
treatment. Viable cells were counted with a hemocytomter using trypan blue exclusion
by diluting samples in a 1 : 1 ratio with trypan blue.
Data Analysis

Data were analyzed with a one-way analysis of variance (ANOV A) on ranks
followed by comparison of experimental groups with the appropriate control group
(Holm-Sidak method) or 2-way ANOV A followed by comparison of experimental groups
with the appropriate control groups (Holm-Sidak method) . SigmaPlot 1 2.5 (Systat
Software Inc., San Jose, CA) and statistical package R (R version 3 . 1 .2 (20 1 4- 1 0-3 1 )
were used for the analyses.
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RESULTS
Galactose increased OXPHOS activity

Oxygen consumption rates in the presence of different mitochondrial substrates
were recorded for permeabilized HepG2 and HepG2-mNT-GFP cells which were prior to
measurements cultured in galactose supplemented medium or high glucose medium.
In the presence of NADH generating substrates malate, glutamate and pyruvate

(MGP) utilized by complex I, HepG2 cells cultured in galactose had significantly lower
respiration rates (state 4 respiration) compared to controls (HepG2 in glucose) .
Pioglitazone treatment did not change oxygen consumption rates in either glucose or
galactose media (Fig. l OA) . Again, in the presence of NADH generating substrates
(MGP), HepG2-mNT-GFP cells cultured in galactose had significantly higher respiration
rates compared to their glucose counterparts. Pioglitazone significantly increased state 4
respirations in HepG2-mNT-GFP cells cultured only in glucose medium (Fig. l OA).
The addition of ADP to the conditions described in Fig. 1 OA resulted in oxygen
consumption rates that were significantly increased in both HepG2 and HepG2-mNT
GFP cells compared to their MGP respiration rates. These elevated respiration rates were
significantly higher in galactose treated HepG2 cells compared to their glucose
counterpart. Elevation of respiration after addition of ADP in HepG2-mNT-GFP cells
was not significantly different in either medium. However, HepG2-mNT-GFP cells
cultured in both glucose and galactose media showed significantly higher respiration
rates compared to HepG2 cells cultured in glucose medium (Fig. l OB).
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Figure 1 0 . Oxygen consumption of permeabilized HepG2 and HepG2-mNT-GFP
(mNT) cells cultured in glucose and DMEM plus galactose (Galactose) in response to
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succinate and (D) MGP, ADP and succinate (LEAKo respiration) (n

=

6, ± SE)

Statistically significant differences in pioglitazone treatment (*), differences between
cell lines in the same medium (' ) and differences between the media of the same cell
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Pioglitazone significantly reduced complex I activity

Oxygen consumption rates were recorded in HepG2 and HepG2-mNT-GFP cells
after treatment with pioglitazone at the concentration of 60 µM in presence of NADH
generating substrates (MGP) and ADP.

Prior to experimentation, those cells were

cultured in 1 0 mM D-galactose supplemented medium. Pioglitazone treatment markedly
reduced oxygen consumption rates of permeabilized HepG2 cells and HepG2-mNT-GFP
cells cultured in either glucose or in galactose medium. Interestingly, HepG2-mNT-GFP
cells cultured in galactose were less sensitive to pioglitazone compared to all other
conditions evaluated (Fig. l OB ) .
Addition o f succinate to the conditions shown i n Fig. l OB generate NADH and
FADH2 utilized by both complexes. The succinate stimulated respiration rates in HepG2
cells cultured in glucose in presence of MGP and ADP increased by an average of 64.5%
and that of in galactose medium increased by 45 .6%. Similarly, respiration in HepG2mNT-GFP cells cultured in glucose medium increased by 62.2% and that of galactose
increased by 57 . 5 % . Both cell types HepG2 and HepG2-mNT-GFP were treated with
pioglitazone at the concentration of 60 µM. Strikingly, after treatment with pioglitazone,
the succinate stimulated respiration rate in presence MGP and ADP increased by 350% in
HepG2 cells cultured in glucose medium and that of in galactose increased by 8 3 . 3 % .
Likewise, succinate stimulated respiration increased b y 3 8 1 . 8 % i n HepG2-mNT-GFP
cultured in glucose medium and that of in galactose medium increased by 222.2%.
Although, succinate stimulated respiration in pioglitazone treated cells increased by an
average of 259%, this increase is 1 9 . 7 % less than the respiration in cells without
pioglitazone treatment (Fig. l OC).
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D-galactose and pioglitazone increased stat 4o (LEAKo) respiration

The

addition

of oligomycin

to

the

conditions

described

in

Fig.

l OC

(MGP+ADP+succinate) allowed state 4o (LEAKo) respiration to be evaluated. HepG2
cells and HepG2-mNT-GFP cells cultured in galactose had significantly higher state 4o
respiration compared to their control counterparts cultured in glucose medium. Both
HepG2 and HepG2-mNT-GFP cells were treated with pioglitazone at the concentration
60 µM. Pioglitazone treatment significantly increased state 4o respiration across all
cultured conditions. Interestingly, pioglitazone treated HepG2 and HepG2-mNT-GFP
cells cultured in galactose medium had further increased state 4o respiration compared to
their glucose counterparts treated with pioglitazone (Fig. l OD).
MitoNEET decreased glutamate dehydrogenase activity after galactose treatment

Addition of glutamate as the only mitochondrial substrate to permeabilized
HepG2

cells

before

uncoupling

allows

evaluating

the

activity

of

glutamate

dehydrogenase. Interestingly, galactose treatment for 2 weeks prior to respirometry lead
to a decrease in oxygen consumption in HepG2-mNT-GFP cells compared to respiration
in HepG2 cells (Fig. 1 l A) . FCCP (Carbonyl cyanide p- [rifluoromethoxyl] -phenyl
hydrozone) is a pure uncoupler (an ionophore) which dissipates the chemiosmotic
gradient leading to loss of regulation of the electron transport system. Maximum
uncoupled rates of intact cells were obtained using FCCP. A significant increase in
uncoupled respiration was observed in HepG2 cells cultured in galactose medium.
However, the uncoupled respiration was significantly reduced in HepG2-mNT-GFP cells
cultured in galactose compared to their control counterpart cultured in glucose (Fig. 1 l B).
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Statistically significant differences between cell lines in the same medium

�)

and

differences between the media of the same cell line (M).
Pioglitazone treatment at the concentration of 60 µM did not show significant uncoupled
respiration in HepG2 cells cultured in either medium glucose or galactose. However,
pioglitazone treatment significantly increased uncoupled respiration in HepG2-mNT-GFP
cells cultured in galactose compared to HepG2 cells cultured in similar conditions (Fig.

1 2).
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Heat dissipation
Galactose reduced energy transduction

HepG2 cells and HepG2-mNT-GFP cells maintained in high glucose medium
were transferred to low glucose containing medium supp lemented with 1 0 mM galactose
2 weeks prior to experimentation and heat flow was evaluated. The results revealed that
galactose significantly reduced the heat output in both the HepG2 and HepG2-mNT-GFP
cells compared to their control counterparts cultured in glucose medium.
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Pioglitazone increased energy transduction over time in galactose supplemented
medium

HepG2 and HepG2-mNT-GFP cells cultured in high glucose medium and
galactose medium were treated with 60 µM pioglitazone and heat dissipation was
monitored every 30 minutes after treatment for 2 hours . Pioglitazone increased heat
dissipation immediately after treatment (30 min) in HepG2 and HepG2-mNT-GFP cells
cultured in glucose medium. However, unlike cells cultured in glucose medium,
pioglitazone treatment did not increase heat dissipation of cells cultured in galactose 30
min after treatment. However, the heat flow measured 2h after treatment was

Table 1 : Cells were cultured and evaluated in either galactose (GAL) or glucose
(GLU) based medium. Cells were treated with acute addition of 60 µM of
pioglitazone or DMSO (vehicle control). Overall heat dissipation was increased after
addition of pioglitazone to cells in glucose medium but not for galactose based
medium (n=8 , ±SE) .
Condition
HepG2
HepG2 + Pio
HepG2-Gal
He�G2-Gal + Pio

30 min
55 .6 ± 3 .00
65 .5 ± 2.38
47 . 1 ± 2.49
46.6 ± 2.47

60 min
56.7 ± 2. 1 1
62.9 ± 2.62
3 8 .7 ± 1 .55
40.6 ± 1 . 80

90 min
5 5 . 3 ± 2.02
6 1 .5 ± 2.33
33.6 ± 1 .40
37.2 ± 1 .50

120 min
53.9 ± 2. 1 2
60.0 ± 2.05
29.9 ± 1 .5 8
34.4 ± 1 .29

significantly higher than 30 min (Table 1 ) .
Repeated two-way ANOVA showed significant interactions between time alone
(T), media composition alone (M) and the interaction between time, media and
pioglitazone treatment on cellular energy transduction (Table 2). The heat generated per
million cells measured every 30 minutes and monitored for 2 h had a strong positive
correlation to each other (Table 3).
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Table 2 : Univariate Type III Repeated-Measures ANOVA Assuming Sphericity of
change in cellular heat dissipation after galactose and pioglitazone treatment
Source of variation
Treatment (T)
Media (M)
TxM
T x Time
M x Time
T x M x Time

DF
1 ,32
1 ,32
1 ,3 2
3 , 96
3 , 96
3 , 96

F
0.78
43 .68
0.87
3 .94
33 .59
3 .29

p
0.38
<0.000 1 * * *
0.35
<0.05 *
<0.000 1 * * *
<0.05 *

Table 3 : Pairwise correlation analyses change in cellular heat dissipation after
galactose and pioglitazone treatment

30 Min
60 Min
90 Min
1 20 Min

30 Min
1

60 Min
0.89
1
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90 Min
0.85
0.99
1

1 20 Min
0.82
0.97
0.99
1

DISCUSSION

The results of the present study show that both treatment with D-galactose, (a
simple reducing sugar) and mitoNEET overexpression significantly increased OXPHOS
capacity in HepG2 cells . Furthermore, treatment of hepatocytes with pioglitazone
significantly reduced OXPHOS (state 3) respiration. Interestingly, galactose treatment,
pioglitazone treatment and mitoNEET overexpression each increased LEAKo respiration
in HepG2 cells .
Mitochondrial respiration is regulated by molecular redox state, the mitochondrial
membrane potential (A\}'m) and proton motive force (PMF/Ap), state of phosphorylation
of ATP/ADP, ion gradient and cellular heat flow in response to intracellular and
extracellular energy demands. Mitochondrial respiration in association with cytoplasmic
glycolytic pathway provides comprehensive insight of cellular pathophysiology (Pesta
and Gnaiger 20 1 2) .
W e found that D-galactose reduces endogenous mitoNEET levels i n HepG2 cells
(Fig. 4). Reduction in mitoNEET levels increases iron content in the mitochondrial
matrix resulting an enhanced mitochondrial respiration capacity (Kusminski et al. , 20 1 2) .
Immortalized cells grown in glucose continuously produce lactate, which inhibits
mitochondrial respiration However, cells in galactose supplemented medium consume
endogenous lactate (Altamirano et al. , 2006) favoring mitochondrial respiration. A
decreased mitoNEET level and the subsequent increase in mitochondrial iron content
combined with endogenous lactate consumption might be the reason for increased
respiration in HepG2 cells cultured in galactose medium (Fig. 1 0) .
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Overexpression of mitoNEET reduces /1.'I'm in adipocytes and decreases iron
content in the mitochondrial matrix thereby increasing reactive oxygen species.
Decreased /1.'I'm is associated with insufficient electron transportation system (ETS)
activity, inefficient substrate supply to the mitochondria or an increase in proton flux
back into the mitochondrial matrix. The observed high rate of respiration in mNT cells
compared to HepG2 cells (Fig. l OB) might be due to iron induced ROS production
(Kusminski et al. , 20 1 2, Simcox and McClain 20 1 3) .
In addition to ATP generation, free radicals are also generated a s a byproduct of
OXPHOS in the inner mitochondrial membrane, which is the major source of reactive
oxygen species (ROS) production and subsequent cellular damage. This process is highly
dependent on /1. 'I'm. Electrons are leaked from complex I and complex III to the oxygen
producing superoxide radicals . This facilitated proton diffusion is termed "proton leak".
Complex I generates superoxide in the mitochondrial matrix which is believed to
contribute much more than complex III to ROS production, whereas complex III
generates ROS in both the inter membrane space and the matrix (Jastroch et al. , 20 1 0) .
Additionally, a-ketoglutarate dehydrogenase also contributes to superoxide generation in
the mitochondrial matrix (Starkov et al. , 2004) . Thermogenesis is also a major functions
of LEAK respiration in adipocytes which is mediated by uncoupling proteins (UCPs)
increasing proton leak and maintaining carbon flux despite low ATP demand in the cells.
According to the uncoupling to survive hypothesis, proton leak has been considered as a
pathway to minimize oxidative damage by moderating PMF and ROS production.
Increased leak respiration in galactose and pioglitazone treated cells in this experiment
(Fig. l OD) might be a mechanism to minimize oxidative damage adjusting 11.'l'm and
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mitochondrial superoxide production (uncoupling to survive) (Divakaruni and Brand
20 1 1 , Jastroch et al. , 20 1 0) .
Pioglitazone reduces the activity o f the mitochondrial complex I b y disassembling
complex

I

subunits

thereby

depleting

cellular ATP

content.

Genes

encoding

mitochondrial complex I subunits and complex III subunits are upregulated as a result of
cellular ATP depletion in HepG2 cells and in mouse liver mitochondria (Garcia-Ruiz et
al. , 20 1 3) . Pioglitazone inhibited state 3 respiration observed in this experiment (Fig.
l OB) is perhaps due to disassembly of complex I subunits.
Galactose treatment induces oxidative stress and mitochondrial damage thereby
dissipating the electrochemical gradient across the inner mitochondrial membrane,
causing a reduction in ATP synthesis (L6pez-Erauskin et al. , 20 1 2) leading to a reduction
in cell proliferation rates and lower carbon flow. This reduced carbon flow might be the
cause behind low heat dissipation in HepG2 cells cultured in galactose medium (Table 1 ) .
In conclusion, three significant findings from these experiments include 1 ) OXPHOS
increases due to galactose treatment or mitoNEET overexpression in liver cancer cells, 2)
Pioglitazone significantly reduces complex I respiration irrespective of mitoNEET levels
and 3) and galactose reduces overall energy transduction in liver cancer cells .
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CHAPTER THREE

CO-IMMUNOPRECIPITATION ASSAY IDENTIFIES BINDING PARTNERS OF
MITONEET
ABSTRACT

The recently discovered protein mitoNEET has been shown to play a central role
in various metabolic processes including mitochondrial function, programmed cell death
(apoptosis), and cell proliferation. However, a clear link between the mechanisms of
mitoNEET' s functions and the physiological processes with which the protein is involved
is still unresolved. A key question that remains is what protein(s) with known function
acts as binding partner of mitoNEET. Knowing this would provide a better understanding
into the mechanism by which mitoNEET integrates into physiological processes. To
detect potential in vivo binding partners of mitoNEET, an in vitro assay termed co
immunoprecipitation (Co-IP) was performed. A combined approach of the Co-IP assay,
proteomics analysis and database search demonstrates that mitoNEET interacts with
mitochondrial, cytoplasmic and nuclear proteins including the mitochondrial matrix heat
shock proteins 60 (Hsp60) , 1 0 (Hsp l O) and aldolase enzymes. These results open new
avenues for further research on elucidation of mitoNEET functions and its importance.
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INTRODUCTION

Mitochondrial functions and dysfunctions set the capacity of the organelle to
supply ATP as per cellular ATP demand (Geldenhuys et al. , 20 14). The exact cellular
functions of the mitoNEET are still unclear but recent reports have been highlighting a
role of mitoNEET in various metabolic and neurodegenerative diseases such as type II
diabetes, Alzheimer' s disease and Parkinson ' s disease. Furthermore, mitoNEET plays a
vital role in mitochondrial bioenergetics, mitophagy, autophagy, apoptosis as well as
cellular growth and development (Geldenhuys et al. , 20 1 1 , Geldenhuys et al. , 20 14). It
has been shown that mitoNEET interacts with other binding partners including ferredoxin
and glutamate dehydrogenase 1 maintaining mitochondrial bioenergetics, mitochondrial
ROS and iron homeostasis, peripheral tissue insulin sensitivity, apoptosis regulation and
mitophagy regulation (Colca et al. , 2004, Paddock et al. , 2007 , Kusmins.ki et al., 20 1 2, ,
Roberts et al. , 20 1 3 and Salem et al. , 20 1 2) . When mitoNEET is in the oxidized state
such as when cells are stressed, mitoNEET transfers its iron-sulfur clusters [2Fe-2S] to an
apo-acceptor protein (e.g. ferredoxin), and functions as a redox sensor center (Zuris et al. ,
20 1 1 ) . Although, the effects of overexpression and knockdown o f mitoNEET i n insulin
sensitivity and ROS homeostasis have been reported in a rodent model (Kusmins.ki et al. ,
20 1 2) (also see Chapter 2), a clear link between the biochemical characteristics of
mitoNEET, and the physiological consequences of mitoNEET levels on mitochondrial
performance and oncogenesis is still unresolved. A key question that remains is, what
protein(s) with known function(s) works as binding partner of mitoNEET to gain insight
into the mechanisms of action of mitoNEET. Our laboratories recently demonstrated the
interaction between glutamate dehydrogenase 1 (GDH l ), described as a regulator of
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insulin, and mitoNEET by forming a redox-sensitive disulfide bond (Roberts et al. ,
20 1 3) . Nevertheless, whether mitoNEET interacts with GDH l in vivo b y the same

mechanism is unknown. To answer this question, co-immunoprecipitation (CO-IP) assays
were performed.
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METHODS
Co-immunoprecipitation assay

Thermo Scientific Pierce™ Crosslink IP/Co-IP Kit (88805) was used to perform
Co-IP assay following the manufacturer' s protocol. Briefly, 2- l Oµg of anti-CISD l
antibody (Mouse monoclonal [2B3] to CISD l ) was cross-linked and immobilized to
protein beads provided. Lysis buffer was added to a monolayer of about 5 x 1 06 HepG2
(ATCC HB-8065 , Manassas, VA) cells. After scraping the cells and centrifuging the
lysate, the supernatant was applied to the antibody immobilized beads. Elutes were used
for SDS-PAGE and Western blot analysis . A pre-cast SDS-PAGE gel (4- 1 5 % TGX, Bio
Rad, Hercules, CA) was

run

and the gel was subjected to silver staining using Thermo

Scientific Pierce Silver Stain for Mass Spectrometry (#24600) kit following the
manufacturer' s protocol. Four protein bands were chosen based on their intensity and
exhibited apparent molecular weights of approximately 1 2, 24, 60 and 70 kDa. The four
bands were excised from the gel, de-stained using Thermo Scientific Pierce Silver Stain
for Mass Spectrometry (24600) kit following the manufacturer' s protocol and sent for
proteomic analysis to be sequenced and identified.
Proteomic Analysis

All of the proteomic analyses were completed at Indiana University School of
Medicine Proteomics Core Laboratory (Indianapolis, IN) . The protein samples were
digested by trypsin (Promega) overnight at 37°C after de-staining (with 1 0 mM DTT in
1 0 mM

ammonium

bicarbonate) and alkylation (with 55 mM iodoacetamide prepared in

10 mM ammonium bicarbonate) of gel bands. Digested peptides were extracted from the
gel spots (with 1 ) 50% ACN /49 .9%H20/0. l % TFA; 2) 99.9% ACN/0. 1 % TFA) and
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inj ected onto NanoAcquity UPLC® column l OOµm

x

l OOmm, l .7µm BEH 1 30 C 1 8

(Analytical column) and NanoAcquity UPLC® Trap column 1 80µm

x

20mm, 5µm

Symmetry C 1 8 (Trapping column) . A linear gradient of 3 to 40% acetonitrile (in water
with 0. 1 % FA) was used to elute the peptides and effluent was electro-sprayed into the
mass spectrometer (Thermo-Fisher Scientific Orbitrap Velos Pro and Waters Acquity
UPLC system) . Blanks were run prior to the sample run to account for any background
signals from solvents or the column. Database search was carried out using SequestTM
algorithms against the latest Human DB from UniProt.
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RESULTS

Proteomics analysis and database searches performed after Co-IP assay using
anti-CISD l antibody for the pull-down experiment (Fig. 1 3 ) detected 8 different proteins.
The majority of proteins identified are localized to the cytoplasm and mitochondrion.
Uniprot

database

searches

for

the

detected proteins revealed the protein
120

Hsp60 (60 kDa chaperonin) which is

85

so

localized to the mitochondrial matrix and

35
25

(3 ,5)-delta(2,4 )-dienoyl-CoA

delta

20

isomerase is localized to mitochondria,
peroxisomes, extracellular exosomes and
membranes .

Heterogeneous

ribonucleoprotein A l

Figure 1 3 . SDS -PAGE gel after silver

nuclear

staining.

is localized to

Proteins

isolated

from

two

complex

replicates of HepG2 cells (A and B) were

subunit 4 is localized to nucleus, nucleus

loaded on to the gel. Boxes shown by whit

speckle and cytoplasm and both were

arrows were incised and sent to proteomics

identifi ed as potential binding partners of

analysis.

mitoNEET. THO complex, a nuclear

prote in ladder (L) .

nucleus

whereas

the THO

Prestained

protein

serves

as

complex containing 5 subunits which is required for transcription elongation through
genes comprising tandem repeat DNA sequences .
Furthermore,

glyceraldehyde-3-phosphate

dehydrogenase

(EC : 1 .2. 1 . 1 2),

fructose-bisphosphate aldolase B (EC :4. l .2. 1 3), and Hsp 10 were identified and all
proteins localize to the cytoplasm (Table 1 ) .
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Table 4: List of proteins detected using Co-IP, proteomics analysis and database search.
SN

Uniprot

Proteins detected

ID

1

THOC4_

THO

HUMAN

(26.9kDa)

subsunit

complex

Gene

Subcellular

names

localization

4 ALYREF
(ALY, BEF,

Nucleus,

nucleus

speckle, cytoplasm

THOC4)

2

ECH I_H

Delta (3 ,5)-delta(2,4)-dienoyl-CoA

UMAN

isomerase, mitochondrial (36 kDa)

ECHJ

Mitochondria

and

peroxysome

(EC : 5 . 3 . 3 . )
3

4

Cytoplasm

Glyceraldehyde-3-phosphate

HUMAN

dehydrogenase (27 . 8 kDa)

membrane-bound

(EC : l .2. 1 . 1 2)

organelle

ALDOB

Fructose-bisphosphate aldolase B

HUMAN

(39.5 kDa) (EC :4. l .2. 1 3)

GAPDH

ALDOB

Cytoplasm
cytoskeleton

Liver-type aldolase
5
6

aldolase ALDOA

Cytoplasm

protein,

Cytoplasm/

H3BPS 8_

Fructose-bisphosphate

HUMAN

(30.4 (kDa) (EC :4. l .2. 1 3)

B 8ZZL8_

10

HUMAN

mitochondrial/Heat shock 1 OkDa

kDa

heat

shock

HSPEJ

mitochondria

protein 1 (Chaperonin 1 0), isoform
CRA_b
7
8

and

E7EUT5_

B7Z7 1 2_

60 kDa heat shock protein (60 kDa HSPDJ

Mitochondrial

HUMAN

chaperonin) (6 1 kDa)

matrix

HOYH80_

Heterogeneous

HUMAN

ribonucleoprotein A l ( 1 9.4 kDa)

nuclear HNRNPAJ
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Nucleus

and

DISCUSSION

In this study we identified THO complex subunit 4, aldolases, HSP proteins and
heterogeneous nuclear ribonucleoprotein A l as potential binding partner of mitoNEET
and the proteins are found in the nucleus, cytoplasm, mitochondria and peroxisomes.
Molecular chaperones bind other nonnative proteins to assist them to fold and gain
functional conformation after translation and guide these nonnative proteins to their
target organelles. They also participate in refolding of misfolded proteins, assembling and
disassembling oligomeric protein structures and regulating biological activities of
regulatory proteins including transcription factors . Furthermore, molecular chaperons
involve in assisting degradation of unwanted proteins in expense of ATP (Bukau and
Horwich 1 998). Although diverse classes of molecular chaperones have been reported,
heat shock protein 70 (Hsp70) and Hsp60 (chaperonin) are the best characterized ones.
But, Hsp60 are quickly sorted into the mitochondria (Itoh et al. , 2002) . Similar to other
Hsps, Hsp70 for example, a complex of mitochondrial Hsp60 and Hsp l O participate in
mitochondrial protein folding and their congregation (Nielsen et al. , 1 999, Campanella et
al. , 2008). Our results documents potential interaction of mitoNEET with mitochondrial
matrix proteins including GDH l (Roberts et al. , 20 1 3) which indicates possible presence
of mitoNEET in mitochondrial matrix as well.
The transcribed RNA molecules are transported to the cytoplasm through the
nuclear pore complexes via export receptors . Unlike small RNAs (transported via simple
export routs), large RNAs (mRNA and rRNA) need complicated ribonucleoproteins
(RNP) and adaptor proteins complex for transcription and export (TREX complex)
(Kohler and Hurt 2007 , Chavez et al 2000) . THO complex subunit 4 (THOC4) in
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association with other proteins such as AL YREF, mediates the recruitment of TREX
complex and nuclear transportation of spliced mRNA. For example, in combination with
THOC5, THOC4 aids in the export of spliced HSP70 mRNA from the nucleus (StraBer et
al. , 2002) . Interaction of mitoNEET with Hsp60, Hsp l O, heterogeneous nuclear
ribonucleoprotein (hnRNP) A l and THO subunit 4 likely suggest its transcription, export
and folding is mediated by the THO complex/ hnRNP A l and aided by Hsp60/Hsp 1 0
complexes . Furthermore, mutation i n HNRNPAJ gene which encodes hnRNP A l causes
symptoms similar to neurodegenerative diseases (Benatar et al. , 20 1 3) and several recent
studies have been reported a crucial role of mitoNEET in neurodegenerative diseases
(Sain et al. , 20 1 1 , Geldenhuys et al. , 20 1 1 ) . In addition to molecular chaperones, these
Hsp help the cells survive to stressful conditions (Zligel and Kaufmann 1 999) .
Hsp60/Hsp 1 0 complex functions as oxidative sensor center in mitochondria (Samali et
al. , 1 999) . Hsp l O has also been reported to play a role in autoimmune inhibition in cancer
(Jia et al. , 20 1 1 ) .
Several metabolic enzymes were identified in the pull-down assay such as
fructose-bisphosphate aldolase (also termed aldolase) an enzyme that reversibly catalyzes
degradation of carbohydrates in glycolysis. Similarly, glyceraldehyde-3 -phosphate
dehydrogenase (GAPDH) was identified which catalyzes the sixth step of glycolysis
(glyceraldehyde-3phosphate to glyceraldehyde 1 ,3-biphosphate) . Furthermore, GAPDH
have been reported to play a role in apoptosis (Tarze et al. , 2007) . One of the causes of
oxidative stress and glucose intolerance phenotypes observed with reduced mitoNEET
levels in a rodent model (Kusminski et al. , 20 1 2) could the interactions of mitoNEET
with GAPDH and aldolases . Furthermore, mitoNEET lowers �-oxidation rate in a rodent
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model (Kusminski et al., 20 1 2) that possibly could be due to an interaction with delta
(3 ,5)-delta(2,4)-dienoyl-CoA isomerase enzyme which catalyzes

isomerization of 3-

trans,5-cis-dienoyl-CoA to 2-trans,4-trans-dienoyl-CoA in lipid metabolism (fatty acid
�-oxidation) pathway (Lou et al. , 1 994) .

In conclusion, the Co-IP assay identified 8

potential binding partners of mitoNEET. These proteins have different localizations and
functions. To confirm the biological relevance of any of these interactions further
research is needed.
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